GLUE
Price
$17.56
Change
-$0.18 (-1.01%)
Updated
Jun 3, 04:59 PM (EDT)
Capitalization
1.66B
64 days until earnings call
Intraday BUY SELL Signals
IMNM
Price
$19.82
Change
+$0.48 (+2.48%)
Updated
Jun 3, 04:59 PM (EDT)
Capitalization
2.19B
77 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

GLUE vs IMNM

Header iconGLUE vs IMNM Comparison
Open Charts GLUE vs IMNMBanner chart's image
GLUE vs IMNM Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
GLUE vs. IMNM commentary
Jun 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GLUE is a Hold and IMNM is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 03, 2026
Stock price -- (GLUE: $17.74 vs. IMNM: $19.32)
Brand notoriety: GLUE and IMNM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GLUE: 110% vs. IMNM: 251%
Market capitalization -- GLUE: $1.66B vs. IMNM: $2.19B
GLUE [@Biotechnology] is valued at $1.66B. IMNM’s [@Biotechnology] market capitalization is $2.19B. The market cap for tickers in the [@Biotechnology] industry ranges from $107.89B to $0. The average market capitalization across the [@Biotechnology] industry is $1.86B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GLUE’s FA Score shows that 1 FA rating(s) are green whileIMNM’s FA Score has 0 green FA rating(s).

  • GLUE’s FA Score: 1 green, 4 red.
  • IMNM’s FA Score: 0 green, 5 red.
According to our system of comparison, GLUE is a better buy in the long-term than IMNM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GLUE’s TA Score shows that 1 TA indicator(s) are bullish while IMNM’s TA Score has 3 bullish TA indicator(s).

  • GLUE’s TA Score: 1 bullish, 6 bearish.
  • IMNM’s TA Score: 3 bullish, 7 bearish.
According to our system of comparison, IMNM is a better buy in the short-term than GLUE.

Price Growth

GLUE (@Biotechnology) experienced а -7.60% price change this week, while IMNM (@Biotechnology) price change was -11.82% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.54%. For the same industry, the average monthly price growth was -1.96%, and the average quarterly price growth was +3.26%.

Reported Earning Dates

GLUE is expected to report earnings on Aug 06, 2026.

IMNM is expected to report earnings on Aug 19, 2026.

Industries' Descriptions

@Biotechnology (-1.54% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IMNM($2.19B) has a higher market cap than GLUE($1.66B). GLUE YTD gains are higher at: 13.138 vs. IMNM (-10.056). GLUE has higher annual earnings (EBITDA): -139.94M vs. IMNM (-231.45M). GLUE has more cash in the bank: 666M vs. IMNM (273M). IMNM has less debt than GLUE: IMNM (4.01M) vs GLUE (39.1M). GLUE has higher revenues than IMNM: GLUE (43M) vs IMNM (9.68M).
GLUEIMNMGLUE / IMNM
Capitalization1.66B2.19B76%
EBITDA-139.94M-231.45M60%
Gain YTD13.138-10.056-131%
P/E Ratio49.25N/A-
Revenue43M9.68M444%
Total Cash666M273M244%
Total Debt39.1M4.01M974%
TECHNICAL ANALYSIS
Technical Analysis
GLUEIMNM
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
89%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
84%
Momentum
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
86%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 6 days ago
88%
Bullish Trend 7 days ago
83%
Declines
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
86%
BollingerBands
ODDS (%)
N/A
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
GLUE
Daily Signal:
Gain/Loss:
IMNM
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
NBGX30.01N/A
N/A
Neuberger Growth ETF
MINN22.39-0.01
-0.06%
Mairs & Power Minnesota Municipal Bd ETF
CBTY19.53-0.04
-0.20%
Calamos Bitcoin 80 Str Alt Prt ETF-July
EWL61.76-0.23
-0.37%
iShares MSCI Switzerland ETF
EIC10.48-0.21
-1.96%
Eagle Point Income Company

GLUE and

Correlation & Price change

A.I.dvisor indicates that over the last year, GLUE has been loosely correlated with CRNX. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if GLUE jumps, then CRNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GLUE
1D Price
Change %
GLUE100%
-9.81%
CRNX - GLUE
42%
Loosely correlated
-5.59%
KURA - GLUE
39%
Loosely correlated
-0.72%
AXON - GLUE
38%
Loosely correlated
+2.78%
XNCR - GLUE
37%
Loosely correlated
-5.00%
IMNM - GLUE
37%
Loosely correlated
-7.03%
More

IMNM and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMNM has been loosely correlated with KURA. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if IMNM jumps, then KURA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMNM
1D Price
Change %
IMNM100%
-7.03%
KURA - IMNM
51%
Loosely correlated
-0.72%
RLAY - IMNM
47%
Loosely correlated
+10.10%
KYTX - IMNM
45%
Loosely correlated
-4.01%
NRIX - IMNM
44%
Loosely correlated
-5.92%
VYGR - IMNM
43%
Loosely correlated
-5.15%
More